期刊文献+

三维适形放射治疗56例中晚期肝癌 被引量:3

Three-dimensional conformal radiotherapy for 56 patients with liver neoplasms
下载PDF
导出
摘要 目的:探讨X射线三维适形放射治疗中晚期肝癌的近期疗效和副反应。方法:56例肝脏恶性肿瘤(62个病灶),其中43例为原发性肝癌,13例为转移性肝癌,采用三维适形放疗技术(3DCRT)治疗,设射野5~7个,治疗次数5~10次,每次间隔1~2天,每次治疗周边剂量4~8 Gy,总剂量DT:30~45 Gy。结果:治疗后1~3个月内根据CT或MRI复查肿瘤退缩情况确定15病灶CR(24%),31个PR(50%),10个NC(16%),6个PD(10%),总有效率(CR+PR)达74%。结论:三维适形放射治疗肝脏恶性肿瘤是一种安全有效的方法,副反应小,能为大多数患者所耐受,有较好的近期疗效,小病灶疗效更好;远期疗效和后期放射损伤有待进一步观察。 Purpose:To evaluate the curative effects and side effects of 3-dimensional conformal radiotherapy (3DCRT) in the treatment of liver carcinoma.Methods:56 patients with liver carcinoma (Forty three patients were primary hepatic carcinoma and 13 liver metastatic tumors) with 62 lesions were treated with 3DCRT for 30~45 Gy/5~10 f/1~2 weeks with fractionated doses ranging from 4Gy to 8Gy.Results:In the 1~3 months after 3DCRT the results examined by CT or MRI showed that the 62 lesions(56 patients) had CR 24% (15/62),PR 50%(31/62),NC 16% (10/62) and PD 10% (6/62).The overall response rate (CR+PR) was 74%.Conclusions:3DCRT is an effective and safe treatment for hepatic malignant tumor and it can be tolerated by most of the patients.The immediate response of tumor is encouraging. The survival rate and late complications remain to be observed.
出处 《中国癌症杂志》 CAS CSCD 2002年第5期411-412,430,共3页 China Oncology
关键词 三维适形放射 肝脏肿瘤 放射治疗 疗效 副反应 3D-CRT liver neoplasm radiotherapy conformal radiotherapy
  • 相关文献

参考文献5

  • 1Tokuuye K , Sumi M , Ikeda H , et al . Technical considerations for fractionated stereotactic of hepatocellular carcinoma [J] . Jpn J Clin Oncol, 1997,27(3):170-173. 被引量:1
  • 2谷铣之 ... ..肿瘤放射治疗学[M],1993.
  • 3王迎选,王所亭主编..现代立体放射治疗学[M].北京:人民军医出版社,1999:363.
  • 4Blomgren H, Lax I, Naslund I, et al . Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator [J], Acta Oncol,1995,34(6):861-870. 被引量:1
  • 5Lax I, Blomgren H, Naslund I, et al . Stereotactic radiotherapy of malignancies in the abdomen [J]. Acta Oncol,1994,33(6):677-683 . 被引量:1

同被引文献19

  • 1谷铣之.现代肿瘤学(临床部分)[M](第2版)[M].北京:北京医科大学、中国协和医科大学联合出版社,1995,2.491. 被引量:1
  • 2Liu CL,Fan ST.Nonresectional tnerapies for hepatocellular carcinoma[].The American Journal of Surgery.1997 被引量:1
  • 3Yu YQ,Yu DB,Zhou XD,et al.Experience with liver resection afterhepatic arterial chemoembolization for hepatocellular carcinoma[].Cancer.1993 被引量:1
  • 4Ono Y,Yoshimasu T,Ashikaga R,et al.Long-term results of lipiodol-transcatheter arterial enbolization with cisplation or doxorubicin for unresectable hepatocellular carcinoma[].American Journal of Clinical Oncology.2000 被引量:1
  • 5Bronowick J P,Vetter D,Dumas F,et al.Transcatheter oily chemoembolization for hepatocellular carcinoma[].Cancer.1994 被引量:1
  • 6Okusaka T,Okada S,Ueno H,et al.Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma[].Oncology.2000 被引量:1
  • 7Mondazzi L,Bottelli R,Brambilla G,et al.Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors[].Hepatology.1994 被引量:1
  • 8Robertson JM,Lawrence TS,Andrews JC,et al.Long-term results of hepatic artery fluorodeoxyuridine and conformal irradiation therapy for primary hepatobiliary cancer[].International Journal of Radiation Oncology Biology Physics.1997 被引量:1
  • 9Ikeda,K.,Kumada,H.,Saitoh,S.,Arase,Y.,Chayama,K.Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma[].Cancer.1991 被引量:1
  • 10GF Stefanini,P Amorati,M Biselli,F Mucci,A Celi,V Arienti,R Roversi,C Rossi,G Re.Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma: An Italian experience[].Cancer.1995 被引量:1

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部